Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
APLT Applied Therapeutics Inc
- Stocks
- Healthcare
- NASDAQ: APLT
Price (delayed)
$0.4852
Market cap
$68.69M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.76
Enterprise value
-$7.91M
Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company's lead drug candidate,
Highlights
The quick ratio has surged by 191% since the previous quarter
The company's EPS rose by 48% QoQ and by 46% YoY
APLT's revenue has dropped by 95% year-on-year
The company's gross profit has shrunk by 95% YoY
Key stats
What are the main financial stats of APLT
Market
Valuations
Earnings
Shares outstanding
141.58M
Market cap
$68.69M
Enterprise value
-$7.91M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.99
Price to sales (P/S)
148.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-17.39
Revenue
$455,000
Gross profit
$455,000
Operating income
-$104.3M
Net income
-$105.62M
EBIT
-$105.62M
EBITDA
-$105.2M
Free cash flow
-$84.31M
Per share
Balance sheet
Liquidity
EPS
-$0.76
EPS diluted
-$0.76
Free cash flow per share
-$0.6
Book value per share
$0.49
Revenue per share
$0
TBVPS
$0.62
Total assets
$86.69M
Total liabilities
$29.69M
Debt
$2.8M
Equity
$57.01M
Working capital
$56.35M
Debt to equity
0.05
Current ratio
3.06
Quick ratio
2.91
Net debt/EBITDA
0.73
Margins
Efficiency
Dividend
EBITDA margin
-23,120.7%
Gross margin
100%
Net margin
-23,214.1%
Operating margin
-22,922.9%
Return on assets
-89.5%
Return on equity
-208.6%
Return on invested capital
N/A
Return on capital employed
-177.8%
Return on sales
-23,214.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
APLT stock price
How has the Applied Therapeutics stock price performed over time
Intraday
10.25%
1 week
15.52%
1 month
31.49%
1 year
-89.54%
YTD
-43.33%
QTD
-0.76%
Financial performance
How have Applied Therapeutics's revenue and profit performed over time
Revenue
$455,000
Gross profit
$455,000
Operating income
-$104.3M
Net income
-$105.62M
Gross margin
100%
Net margin
-23,214.1%
APLT's revenue has dropped by 95% year-on-year
The company's gross profit has shrunk by 95% YoY
Applied Therapeutics's operating income has plunged by 62% YoY and by 13% from the previous quarter
The company's net income rose by 44% QoQ and by 12% YoY
Price vs fundamentals
How does APLT's price correlate with its fundamentals
Growth
What is Applied Therapeutics's growth rate over time
Valuation
What is Applied Therapeutics stock price valuation
P/E
N/A
P/B
0.99
P/S
148.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-17.39
The company's EPS rose by 48% QoQ and by 46% YoY
APLT's price to book (P/B) is 98% less than its last 4 quarters average of 46.4
APLT's revenue has dropped by 95% year-on-year
Efficiency
How efficient is Applied Therapeutics business performance
The return on assets has surged by 68% year-on-year and by 47% since the previous quarter
The return on equity has surged by 64% since the previous quarter
Dividends
What is APLT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for APLT.
Financial health
How did Applied Therapeutics financials performed over time
The company's total assets is 192% higher than its total liabilities
The quick ratio has surged by 191% since the previous quarter
The current ratio has soared by 189% from the previous quarter
APLT's debt is 95% smaller than its equity
The company's debt to equity has shrunk by 85% QoQ
APLT's debt is up by 42% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.